Moreover, inhibition of EGFR/HER2 signaling can inhibit prostate cancer cell growth in vitro and in vivo[17], [18] as well as AR transcriptional activity, protein stability, DNA binding, and Ser 81 phosphorylation [19]. This evidence concerns the gene ERBB2 and prostate carcinoma.